BMQ | Beliefs about Medicines Questionnaire |
CI | Chief Investigator |
CoP | Community of Practice |
CRF | Case Report Form |
CTU | Clinical Trials Unit |
DA | Decision Aid |
DCS | Decisional Conflict Scale |
DMC | Data Monitoring Committee |
DNA | Do/Did Not Attend |
DST | Decision Support Tool |
ERO | Evidenced Resources for Osteoporosis |
FPS | Fracture Prevention Service |
FLS | Fracture Liaison Service |
FRAX® | Fracture Risk Assessment Tool |
GDPR | General Data Protection Regulation |
GP | General Practitioner |
ID | Identification |
iFraP |
improving uptake of
Fracture
Prevention drug
treatments |
IMD | Indices of Multiple Deprivation |
ITT | Intention To Treat |
MCID | Minimum Clinically Important Difference |
MDC | Minimum data collection |
MRC | Medical Research Council |
MRR | Medical Record Review |
NHS | National Health Service |
NICE | National Institute for Health and Care Excellence |
PAG | Patient Advisory Group |
PI | Principal Investigator |
PIL | Participant Information Leaflet |
PPIQ | Patient-Professional Interaction Questionnaire |
QoL | Quality of Life |
RCT | Randomised Controlled Trial |
REC | Research Ethics Committee |
ROS | Royal Osteoporosis Society |
SAE | Serious Adverse Event |
SD | Standard Deviation |
SIMS | Satisfaction with medicines information |
SOP | Standard Operating Procedure |
TM | Trial Manager |
TMG | Trial Management Group |
TSC | Trial Steering Committee |
UK | United Kingdom |
VoI | Value of Information |